Much progress has been made in genomics research, says Stephen Baker, but the impact on public health is limited in the developing world.

Health systems in developing nations aren't ready for the diseases that accompany ageing, writes Priya Shetty.

Healthcare policies and research strategies in developing countries must adapt to the new big killers, says Priya Shetty.

Developing world scientists should be empowered to do their own medical genomics research, say Carlos D. Bustamante and colleagues.

After recent gains against trypanosomiasis, new diagnostic and treatment tools mean we can make the final push, says Priya Shetty.

Vietnam is making rapid progress in developing biotechnology for a healthier society, says biotech expert Thai Nguyen.

Livestock genebanks are needed to ensure the world's future food supply, says livestock expert Carlos Seré.

Jim Kaput explains why efforts to tackle malnutrition should consider nutrigenomics — the interplay between food and genetic make-up.

Poor countries need support to participate in genomics research, say Josefina Coloma and Eva Harris in PLoS Medicine.

Translating genetics research is easier in agriculture than medicine, says a Nature Genetics editorial, and existing technologies can be used.

Tewolde Egziabher and other SciDev.Net readers join the debate on the relevance of the UN biodiversity convention's Cartagena Protocol on genetically modified organisms.

Peter Raven and colleagues argue that it is time to sequence the genome of cassava, a crop vital to the health and livelihoods of half a billion people.

David Weatherall says that pharmacogenetics — or tailor-made medicine — could be the future, but needs to be evaluated carefully before we depart from traditional diagnostic techniques.

Wilmot James argues that South Africa could take part in high-level biological research — as long its government provides promised funding.

Although easy access to scientific information can pose security risks, the benefits of such openness far outweigh any potential danger, argues this editorial in The Lancet.

Kannan Sivaprakasam argues why India should not let the genomics revolution pass it by, and explains how the nation stands to gain from actively encouraging investment in genomics.

David J. Weatherall urges genomic technologists to take a global view of disease — or risk widening the North-South healthcare gap.

José Luis Ramírez and David Holmes argue that countries in Latin America must develop close collaboration in genomics and proteomics if they are to reap the benefits that these new disciplines offer.

Ala' Alwan and Bernadette Modell argue that most developing nations urgently need to incorporate genetic approaches such as DNA diagnosis into their health services.

A Nature editorial argues that a global post-genomics research effort to combat malaria could deliver far-reaching solutions.